Skip to content

Roivant Sciences ROIV Market capitalization

Market capitalization at other companies

Amgen logo
AmgenAMGN
$189.67B+13.3%
Moderna logo
ModernaMRNA
$20.15B+83.8%
Royalty Pharma logo
Royalty PharmaRPRX
$20.55B+52.4%
ALN
Alnylam PharmaceuticalsALNY
$43.88B+25.6%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.22B+19.9%
Incyte logo
IncyteINCY
$18.73B+59.9%

Other financials

Income statement

See full
Revenue$2.5M-66.7%

Balance sheet

See full
Cash & equivalents$1.4B+1,411%
Total debt$107.4M+7.3%
Total equity$4.5B-3.4%
Total assets$5.7B+5.0%

Cash flow

See full
Operating cash flow-$163.8M+5.1%
CapEx$1.3M+55.5%
Free cash flow-$165.1M+4.8%

Valuation

See full
Enterprise value$21.13B+157%
P/S2,716.9×+2,436×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio18.4×-15.1×

Where this comes from

Computed from the period-end share price: $19.82B.

The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Roivant Sciences's market capitalization?
Roivant Sciences (ROIV) reported market capitalization of $19.82B in Q1 2026.
How has Roivant Sciences's market capitalization changed year-over-year?
Roivant Sciences's market capitalization increased by 175.4% year-over-year, from $7.2B to $19.82B.
What is the long-term trend for Roivant Sciences's market capitalization?
Over 4 years (2021 to 2025), Roivant Sciences's market capitalization has grown at a 22.5% compound annual growth rate (CAGR), from $23.59B to $53.09B.
What does market capitalization mean?
What the stock market says the company's equity is worth.
How do you interpret market capitalization?
A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
How does market capitalization compare across companies?
Comparable across companies as a size class; the input to every equity-price valuation multiple.